Astria Therapeutics, Inc. Deferred Revenue
Astria Therapeutics, Inc. had Deferred Revenue of $4.50 million as of 2025-09-30, per its 10-Q filed 2025-11-12.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:DeferredRevenueCurrent · last filed 2025-11-12
- 2025-09-30: Deferred Revenue, Current $4.50M.
| Period end | Deferred Revenue, Current |
|---|---|
| 2025-09-30 | $4.50M 10-Q · filed 2025-11-12 |